Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-004604
Filing Date
2022-02-03
Accepted
2022-02-03 16:30:28
Documents
2
Period of Report
2022-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4042
2 EX-24 DOCUMENT attachment1.htm EX-24 4338
  Complete submission text file 0000899243-22-004604.txt   9877
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLDG. 1400 CAMBRIDGE MA 02139
Business Address
Beckman Daniella (Reporting) CIK: 0001513422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39485 | Film No.: 22588853

Mailing Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142
Business Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142 (857) 320-4900
Tango Therapeutics, Inc. (Issuer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations